Wendy S. Johnson, Chief Development Officer at Reneo Pharmaceuticals, Inc. (RPHM), sold 111,736 shares at $8.50 ($950K) on 2021-07-14, disclosed to the SEC on 2021-07-15.
Open-market sale of $950k RPHM by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |